HITKIT
DEAD

Serial Number

90346293

Owner

HIT KIT, Inc.

Attorney

George Likourezos

Filing Date

Nov 28, 2020

Add to watchlist:

No watchlists yet
View on USPTO

HITKIT Trademark

Serial Number: 90346293

HITKIT is a trademark filed by HIT KIT, Inc. on November 28, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

HIT KIT, Inc.

Port Jefferson, NY 11777

Entity Type: 03

NEW HILL VENTURES LLC

16192 COASTAL HIGHWAY
LEWES, DE 19958

Entity Type: 16

Trademark Details

Filing Date

November 28, 2020

Registration Date

Not Registered

Published for Opposition

December 7, 2021

Goods & Services

Pharmaceuticals, namely, a partial agonist of N-methyl-D-aspartame (NMDA) receptors at low dose and a partial antagonist of NMDA at high dose, an inhibitor of microglial activation, and a modulator of NMDA receptors; antibiotics; pharmaceuticals and antibiotics for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury; pharmaceuticals and antibiotics for reversing the damage caused by concussion or traumatic brain injury

Retail store services featuring drug delivery systems, pill packets, pharmaceuticals, antibiotics, and drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury

Medical services, namely, providing medical services using drug delivery systems, pill packets, pharmaceuticals, antibiotics, and drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury

Drug delivery system, namely, an intramuscular autoinjector and an intramuscular drug delivery autoinjector; drug delivery system for administering drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury, namely, an intramuscular autoinjector, and an intramuscular needle-based injection system; an intramuscular needle-based injection system for administering drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury; drug delivery system for reversing the damage caused by concussion or traumatic brain injury, namely, intramuscular autoinjector and an intramuscular needle-based injection system

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 2, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 2, 2024 ABN6
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 11, 2024 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 1, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jan 30, 2024 EX4G
SOU EXTENSION 4 FILED
Jan 30, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 30, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 28, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jul 26, 2023 EX3G
SOU EXTENSION 3 FILED
Jul 26, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 26, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 28, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jan 26, 2023 EX2G
SOU EXTENSION 2 FILED
Jan 26, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 26, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 16, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jul 14, 2022 EX1G
SOU EXTENSION 1 FILED
Jul 14, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 14, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 1, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 7, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 7, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 1, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 12, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 12, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 12, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 12, 2021 CNEA
EXAMINER'S AMENDMENT ENTERED
Oct 12, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 12, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 12, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 12, 2021 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 20, 2021 GNRN
NON-FINAL ACTION E-MAILED
May 20, 2021 GNRT
NON-FINAL ACTION WRITTEN
May 20, 2021 CNRT
ASSIGNED TO EXAMINER
May 13, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 3, 2021 NWOS
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Dec 7, 2020 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 7, 2020 PARI
NEW APPLICATION ENTERED
Dec 2, 2020 NWAP